COCETTA, VERONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.863
AS - Asia 3.565
EU - Europa 2.234
SA - Sud America 643
AF - Africa 503
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 18
Totale 11.870
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.547
SG - Singapore 1.220
IT - Italia 859
CN - Cina 646
VN - Vietnam 523
BR - Brasile 419
HK - Hong Kong 332
FR - Francia 141
DE - Germania 136
PL - Polonia 132
FI - Finlandia 117
IN - India 112
GB - Regno Unito 111
SE - Svezia 109
IQ - Iraq 64
NL - Olanda 64
UA - Ucraina 63
BD - Bangladesh 61
CA - Canada 56
TR - Turchia 56
RU - Federazione Russa 51
MX - Messico 47
AR - Argentina 45
EC - Ecuador 40
ID - Indonesia 40
ZA - Sudafrica 40
PH - Filippine 39
JP - Giappone 35
CZ - Repubblica Ceca 32
ES - Italia 32
IR - Iran 32
CH - Svizzera 31
MA - Marocco 29
PK - Pakistan 28
AT - Austria 26
SA - Arabia Saudita 26
VE - Venezuela 26
AZ - Azerbaigian 21
NP - Nepal 21
UZ - Uzbekistan 21
AE - Emirati Arabi Uniti 20
MY - Malesia 20
CO - Colombia 19
HR - Croazia 19
IE - Irlanda 19
JO - Giordania 19
RS - Serbia 19
AU - Australia 18
CL - Cile 18
IL - Israele 18
JM - Giamaica 18
TH - Thailandia 18
AO - Angola 17
BF - Burkina Faso 17
CY - Cipro 17
PY - Paraguay 17
TJ - Tagikistan 17
AL - Albania 16
BZ - Belize 16
CM - Camerun 16
DZ - Algeria 16
GM - Gambi 16
KE - Kenya 16
KR - Corea 16
PE - Perù 16
PT - Portogallo 16
UY - Uruguay 16
HU - Ungheria 15
IS - Islanda 15
LB - Libano 15
LU - Lussemburgo 15
PS - Palestinian Territory 15
RE - Reunion 15
RO - Romania 15
SI - Slovenia 15
TT - Trinidad e Tobago 15
BA - Bosnia-Erzegovina 14
BJ - Benin 14
BY - Bielorussia 14
CR - Costa Rica 14
EE - Estonia 14
EG - Egitto 14
ET - Etiopia 14
GT - Guatemala 14
NI - Nicaragua 14
SD - Sudan 14
SN - Senegal 14
BB - Barbados 13
BO - Bolivia 13
CU - Cuba 13
DO - Repubblica Dominicana 13
GF - Guiana Francese 13
LV - Lettonia 13
LY - Libia 13
MU - Mauritius 13
TN - Tunisia 13
TZ - Tanzania 13
GE - Georgia 12
GN - Guinea 12
HN - Honduras 12
Totale 11.355
Salva come PNG Salva come JPEG
Città #
Singapore 724
Ashburn 671
San Jose 657
Hong Kong 301
Fairfield 291
Padova 234
Chandler 222
Beijing 181
Ho Chi Minh City 176
Santa Clara 176
Woodbridge 147
Cambridge 145
Ann Arbor 133
Seattle 128
Hanoi 120
Houston 120
Boardman 104
Wilmington 104
Los Angeles 102
New York 91
Bytom 87
Helsinki 85
Medford 68
Princeton 68
Lauterbourg 65
Milan 65
Munich 58
Des Moines 46
San Diego 37
Baghdad 35
Rome 34
São Paulo 34
Da Nang 33
Warsaw 31
Orem 28
Nanjing 27
Malo 26
Montreal 25
Tokyo 25
Buffalo 23
Council Bluffs 23
Dallas 23
Denver 23
Haiphong 23
Amsterdam 22
The Dalles 22
Brooklyn 21
Johannesburg 21
Mexico City 21
Roxbury 21
Atlanta 20
Baku 20
Chicago 20
Poplar 20
Tashkent 20
Amman 19
Chennai 19
Stockholm 19
Redondo Beach 18
Guangzhou 17
Turku 17
Dublin 16
Phoenix 16
Basingstoke 15
Frankfurt am Main 15
Manchester 15
Palermo 15
Zagreb 15
Dakar 14
Dushanbe 14
Istanbul 14
Managua 14
Montevideo 14
Rio de Janeiro 14
Boston 13
Lugano 13
Naples 13
Ouagadougou 13
Quito 13
Washington 13
Ankara 12
Belgrade 12
Biên Hòa 12
Cagliari 12
Conakry 12
Falkenstein 12
Havana 12
Lahore 12
London 12
Nairobi 12
New Delhi 12
Parma 12
Reykjavik 12
Tallinn 12
Banjul 11
Belo Horizonte 11
Bridgetown 11
Cotonou 11
Kingston 11
Limassol 11
Totale 6.659
Salva come PNG Salva come JPEG
Nome #
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells 306
Anti-senescence activity of Salvia haenkei on skin cellular model identified by integrated senescence-screening assay 272
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 263
Polyoxometalates-peptides conjugates for cancer cell targeting: a structural investigation 262
Mitochondrial Involvement in Cisplatin Resistance 256
A fixed combination of probiotics and herbal extracts attenuates intestinal barrier dysfunction from inflammatory stress in an in vitro model using Caco-2 cells. 252
Further assessment of Salvia haenkei as an innovative strategy to counteract skin photo-aging and restore the barrier integrity 251
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy 244
Peculiar combinations of individually non-pathogenic missense mitochondrial DNA variants cause low penetrance Leber’s hereditary optic neuropathy 243
Identification of Salvia haenkei as gerosuppressant agent by using an integrated senescence-screening assay 242
Lindqvist polyoxovanadate-peptides conjugates for cancer cell targeting 224
In Vitro Cultured Melissa officinalis Cells as Effective Ingredient to Protect Skin Against Oxidative Stress, Blue Light, and Infrared Irradiations Damages 209
Interaction between Mitochondrial DNA Variants and Mitochondria/Endoplasmic Reticulum Contact Sites: A Perspective Review 206
Protective effects of ψ taraxasterol 3-O-myristate and arnidiol 3-O-myristate isolated from Calendula officinalis on epithelial intestinal barrier 201
Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress 201
Milk kefir enriched with inulin-grafted seed extract from white wine pomace: chemical characterisation, antioxidant profile and in vitro gastrointestinal digestion 188
Anti-inflammatory activity of a fixed combination of probiotics and herbal extract in an in-vitro model of intestinal inflammation by stimulating Caco-2 cells with LPS-conditioned THP-1 cells medium 187
New insights in cisplatin-resistance: role of metabolic reprogramming in cancer cells 185
Clinical evidence of interaction between nutraceutical supplementation and platinum-based chemotherapy 183
Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal Extracts in an In Vitro Model of Intestinal Epithelial Barrier Dysfunction 181
The SARS-CoV-2 spike protein binds and modulates estrogen receptors 179
Silybin counteracts doxorubicin resistance by inhibiting GLUT1 expression 176
Serenoa repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH) 175
Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy 174
Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2 172
Overcome cisplatin -resistance by targetin glucose-6-phosphate dehydrogenase with the combination of liposomal cisplatin and 6-amino nicotinamide 164
Anti-ageing activity of Salvia haenkei in an in vitro epidermal model 163
Study of metabolic reprogramming and identification of new pharmacological targets in chemotherapy resistance 158
Retrospective Analysis of the Effect of Postmenopausal Women Medications on SARS-CoV-2 Infection Progression 156
Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives 150
Novel Adenosine Triphosphate-Based Nutraceutical Formulation to Prevent Non-Steroidal Anti-Inflammatory Drug Enteric Cell Toxicity: Preliminary In Vitro Evidence 145
Metabolic reprogramming in triple negative breast cancer cells: role of glutamine and glucose in cisplatin resistance 143
Anti-senescence activity of Salvia Haenkei on a skin cellular model 143
Mitochondrial phenotyping of doxorubicin-resistant osteosarcoma cells 142
Plumbagin Induces Cell Cycle Arrest and Apoptosis in A431 Cisplatin-Resistant Cancer Cells 141
Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy 141
Silybin as a new tool to counteract doxorubicin resistance by targeting glucose uptake 140
Maintenance of intestinal epithelial barrier integrity by a combination of probiotics, herbal extract, and vitamins 139
Silybin, curcumin and quercetin as metabolic modulators in human resistant cancer cells 138
CHARACTERIZATION OF MITOCHONDRIAL METABOLISM OF DOXORUBICIN-RESISTANT OSTEOSARCOMA CELLS 137
Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses CisplatinResistance: new pharmacological approach using Cisplatin liposome and 6-amino nicotinamide combination 135
Contribution of Mitochondrial Activity to Doxorubicin-Resistance in Osteosarcoma Cells 133
Imbalance of mitochondrial "shaping proteins" and cisplatin resistance 133
Natural compounds as metabolic modulators in resistant cancer cells models 133
UN NAFTOCHINONE ESTRATTO DALLA PIANTA PLUMBAGO ZEYLANICA L. INDUCE MORTE CELLULARE DELLE CELLULE RESISTENTI AL CISPLATINO 133
Role of mitochondria in cisplatin-resistance phenomena 132
VALUTAZIONE DELL’ATTIVITA’ ANTI-INVECCHIAMENTO DELL’ESTRATTO AS PER APPLICAZIONE FITOCOSMETICA 131
Mitochondria as cisplatin targets: new apporach to counteract resistance mechanism 131
VALIDAZIONE IN VITRO DI UNA COMBINAZIONE DI SERENOA REPENS E URTICA DIOICA PER LA TERAPIA DELL'IPERPLASIA PROSTATICA BENIGNA 131
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 130
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 130
Links between cancer metabolism and cisplatin resistance 129
Natural compounds as possible modulators of lipid metabolism in cisplatin-resistant cancer cells 128
Mitophagic/autophagic inhibitors as new strategy to overcome cisplatin resistance in cancer 127
Targeting glucose-6-phosphate dehydrogenase by 6-amino nicotinamide in combination with liposomal cisplatin as a strategy to sensitize ovarian resistant cancer cells 126
Mitochondrial remodeling involved in cisplatin resistance 124
Potential effect of Salvia Haenkey on in vitro wound healing 123
Cannabis Sativa modulates epithelial permeability in an in vitro intestinal inflammation model 123
Curcumin and Cisplatin as new chemotherapeutic compounds in order to overcome cisplatin resistance 121
Mitochondrial alterations involved in cisplatin resistance phenomena 119
IDENTIFICAZIONE DI ESTRATTI NATURALI CON PROMETTENTE APPLICAZIONE IN FITOCOSMESI 119
GLUTAMINE METABOLISM IN TRIPLE-NEGATIVE BREAST CANCER AND ITS ROLE IN CISPLATIN RESISTANCE 117
Lipid-metabolic reprogramming in ovarian carcinoma cell lines resistant to cisplatin 115
SILYBIN: A NATURAL COMPOUND ABLE TO OVERCOME DOXORUBICIN RESISTANCE PHENOMENA 112
Targeting glucose-6-phosphate dehydrogenase with a combination of liposomal cisplatin and 6-amino nicotinamide as new strategy to overcome cisplatin-resistance 110
Natural polyphenol sensitize cancer cells to cisplatin effect on cell cycle 109
Natural compounds as metabolic modulators in resistant cancer models 107
Calu-3 cells as in vitro model of bronchial epithelium for pharmacological studies of natural compounds 106
Silybin chemosensitize doxorubicin-resistant cells by targeting GLUT1 106
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 104
Antioxidant and anti-inflammatory activities of Cannabis Sativa in epithelial intestinal cell 96
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 95
Cannabis Sativa L. modulates epithelial permeability in an in vitro intestinal inflammation model 93
Natural compounds as metabolic modulators in resistant cancer cell models 89
Natural polyphenols as chemosensitizer: studies in resistant cancer cells. 76
Silybin glycolysis inhibitor as promising agent in chemotherapy 74
Natural polyphenols chemosensitize cisplatin-resistant cells through cell cycle modulation 72
Sviluppo di un decongestionante nasale a base fitoterapica 71
Totale 11.975
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.611
article - articoli 18.765
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 339
Totale 52.715
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021118 0 0 0 0 0 0 0 0 0 0 84 34
2021/2022667 17 117 42 22 23 69 27 39 80 16 29 186
2022/2023598 129 46 21 36 120 59 6 32 80 3 47 19
2023/2024554 24 59 60 45 42 76 49 70 16 13 39 61
2024/20252.078 117 102 97 89 319 58 129 203 111 82 304 467
2025/20266.726 415 586 792 1.091 771 313 853 579 698 431 197 0
Totale 11.975